Adia Med Sells 30% Stake in Adia Labs for $1.5 Million
Adia Med Inc. has sold a 30% interest in its subsidiary Adia Labs LLC to Live Oak Health (dba QCM Biologics) for $1.5 million. The sale is accompanied by a distribution partnership.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Adia Med sells 30% stake in Adia Labs to Live Oak Health for $1.5 million
Adia Med agreed to sell 30% of subsidiary Adia Labs to Live Oak Health for $1.5 million, comprising $1 million cash and a $500,000 promissory note. The transaction is contingent on the wire transfer by Sept. 30, 2026.